Vaccinex, Inc. (VCNX) stock
VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)
Close on Oct 19, 2026Market cap $3.22MP/E –Yield –
Vaccinex cash
Cash and short-term investments held at the end of each period.
Vaccinex's cash was $1.11M at Dec 31, 2024. For fiscal 2024 it was $1.11M, down 27.9% from the year before. The highest annual figure on record is $19.72M in fiscal 2018.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.11M | -27.9% |
| FY2023 | Dec 31, 2023 | $1.54M | -76.0% |
| FY2022 | Dec 31, 2022 | $6.39M | -25.6% |
| FY2021 | Dec 31, 2021 | $8.59M | -18.9% |
| FY2020 | Dec 31, 2020 | $10.60M | +281.7% |
| FY2019 | Dec 31, 2019 | $2.78M | -85.9% |
| FY2018 | Dec 31, 2018 | $19.72M | +371.9% |
| FY2017 | Dec 31, 2017 | $4.18M | +151.7% |
| FY2016 | Dec 31, 2016 | $1.66M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $1.11M | -27.9% |
| Q3 FY2024 | Sep 30, 2024 | $2.91M | +2188.2% |
| Q2 FY2024 | Jun 30, 2024 | $233.00K | -87.8% |
| Q1 FY2024 | Mar 31, 2024 | $2.97M | -10.6% |
| Q4 FY2023 | Dec 31, 2023 | $1.54M | -76.0% |
| Q3 FY2023 | Sep 30, 2023 | $127.00K | -98.2% |
| Q2 FY2023 | Jun 30, 2023 | $1.91M | -83.3% |
| Q1 FY2023 | Mar 31, 2023 | $3.32M | -80.2% |
| Q4 FY2022 | Dec 31, 2022 | $6.39M | -25.6% |
| Q3 FY2022 | Sep 30, 2022 | $7.19M | -47.7% |
| Q2 FY2022 | Jun 30, 2022 | $11.40M | -49.1% |
| Q1 FY2022 | Mar 31, 2022 | $16.80M | -42.8% |
| Q4 FY2021 | Dec 31, 2021 | $8.59M | -18.9% |
| Q3 FY2021 | Sep 30, 2021 | $13.74M | -19.6% |
| Q2 FY2021 | Jun 30, 2021 | $22.39M | +4155.7% |
| Q1 FY2021 | Mar 31, 2021 | $29.39M | +1079.8% |
| Q4 FY2020 | Dec 31, 2020 | $10.60M | +281.7% |
| Q3 FY2020 | Sep 30, 2020 | $17.09M | +99.3% |
| Q2 FY2020 | Jun 30, 2020 | $526.00K | -90.0% |
| Q1 FY2020 | Mar 31, 2020 | $2.49M | -67.3% |
| Q4 FY2019 | Dec 31, 2019 | $2.78M | -85.9% |
| Q3 FY2019 | Sep 30, 2019 | $8.58M | -68.7% |
| Q2 FY2019 | Jun 30, 2019 | $5.28M | +306.7% |
| Q1 FY2019 | Mar 31, 2019 | $7.63M | +487.6% |
| Q4 FY2018 | Dec 31, 2018 | $19.72M | +371.9% |
| Q3 FY2018 | Sep 30, 2018 | $27.38M | +6282.1% |
| Q2 FY2018 | Jun 30, 2018 | $1.30M | +11.3% |
| Q1 FY2018 | Mar 31, 2018 | $1.30M | -21.9% |
| Q4 FY2017 | Dec 31, 2017 | $4.18M | – |
| Q3 FY2017 | Sep 30, 2017 | $429.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $1.17M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.66M | – |
See a number that looks wrong?